What you need to know about injectable PrEP
from Revolutionary Health Hosted by CNP Podcast Network
Dr. David Malebranche (@DMalebranche) talks injectable PrEP and HIV research. Please See Two Clarifications From Dr. Malebranche: 1. In the video it is stated the HIV incidence rate in the Cabotegravir arm of HPTN 083 study was .038%. It's actually 0.38%. 2. Clarification on Studies: HPTN 083 is the study recently released and was with Cisgender MSM and Transgender Women. HPTN 084 is the study focused on Cisgender Women.
Embed this episode
No transcript yet.